Navigation Links
QIAGEN Fast Cycling PCR Kit

are GC-rich. Unlike other commonly used PCR additives such as DMSO, Q-Solution is used at just one working concentration, it is nontoxic, and PCR purity is guaranteed.


Applications
The QIAGEN Fast Cycling PCR Kit enables increased PCR throughput on any thermal cycler and is suitable for general PCR, complex genomic templates, and complex cDNA templates. The kit can be used with standard as well as fast-ramping thermal cyclers.





Order your kit today at www.qiagen.com/FastCyclingPCR


back to top
'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. The QIAGEN Guide to Animal Cell Culture
2. The QIAGEN Guide to Animal Cell Culture
3. The QIAGEN Guide to Animal Cell Culture
4. The QIAGEN Guide to Animal Cell Culture
5. The QIAGEN Guide to Animal Cell Culture
6. The QIAGEN Guide to Animal Cell Culture
7. QIAGEN Instrument Service insist on the best in service and support
8. QIAGEN Multiplex PCR Handbook
9. QIAGEN Multiplex PCR Kit
10. QIAGEN Plasmid Kits
11. Laser microdissection and nucleic acid purification - a Leica - QIAGEN cooperation

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: QIAGEN Fast Cycling PCR Kit

(Date:11/6/2009)...EO, Calif., Nov. 6 ,...transfer of Qutenza(TM) E.U. Marketing Authorizati...nt progress in commercial readiness activities Ex... Director, Marketing; and Director, Commercial Ope... director and Audit Committee chairman , Up...
(Date:11/6/2009)..., Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biote...e "Company") today announced updated results from ...ients with sarcomas metastatic to the lung in a po...ssue Oncology Society Meeting held in Miami Beach,...sentation, entitled "A Phase II Study of Intraveno...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010...ich is set to take place on February 22-24, 2010 i...day conference we will highlight key issues in for...share their experiences. , ...agenda for Arrowhead’s 2010 Personalized Me...
(Date:11/5/2009)...SBURG, Md., Nov. 5 GenVe...cial results for the third quarter ended September...ion ($0.04 per share) for the three months ended S...illion ($0.08 per share) in the comparable quarter...2009, GenVec,s net loss was $14.1 million ($0.15 p...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
...ay 29 The Gerresheimer,Group today opened a new p...The high-tech production facility constructed in D...ers. Specializing in high-quality pharmaceutical,v...s the pharma & life,science industry on both a...EO of Gerresheimer AG, describes the investment as...
...RNewswire-FirstCall/ - YM BioSciences Inc. (NYSE A... that identifies, develops and commercializes diff...announced that a poster presentation will report r... BIOMAb/TheraCIM/h-R3) in patients with head and n... India), a licensee of CIMAB SA, YM,s licensor, at...
...0th patient was supported with the,Berlin Heart EX...nown as the,"Berlin Heart") since the first implan...onth-old girl, received the device at the Children...ssfully transplanted in the meantime. , Alejan...h left,ventricular non compaction and dilative car...
Other Biology Technology:Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China 2Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China 3YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING 2YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING 3500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device 2
(Date:11/5/2009)...The National Association of Biology Teachers (NABT...f biological sciences at Naugatuck Valley Communit...he 2009 Evolution Education Award during the NABT ...eld 11-14 November 2009 in Denver, Colorado. , T... American Institute of Biological Sciences,(AIBS)...
(Date:11/4/2009)... LEADS: (top news in natural science) , Unit...tates uses less water today than it did 35 years a...ines in water use are partly attributable to alter...ficient irrigation systems. According to the lates...used in the United States goes to cooling thermoel...
(Date:11/4/2009)...The Singapore laboratory that deciphered the DNA c...) and elephant shark, has joined The Genome 10K Pr...ble repository of DNA sequences on 10,000 species ... scale that currently can not be achieved. , Par... a paper published in the Nov. 5, 2009 issue of th...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Singapore scientists join international study of 10,000 vertebrates' genomes 2American Pacific to Release Financial Results and Hold Fiscal 2009 Third Quarter Investor Teleconference 53006 1American Pacific to Release Financial Results and Hold Fiscal 2009 Third Quarter Investor Teleconference 53006 2Thousands of Maine Residents Could Lose Private Insurance Study Shows 53001 1Thousands of Maine Residents Could Lose Private Insurance Study Shows 53001 2Cell Therapeutics Inc Announces Closing of Public Offering of Common Stock and Warrants 52996 1Cell Therapeutics Inc Announces Closing of Public Offering of Common Stock and Warrants 52996 2
...g to the growing popularity of a plant-based sweet...y announced it is developing a new standard to be ...ll help food and beverage manufacturers assure the...omments from the food and beverage industry as wel...new standard for this new sweetener, Rebaudioside ...
...g? , A new study suggests that while health care ...conomy, achieving a substantial, sustainable reduc...he author, who completed health care policy litera...spite far greater expenditures, US hospitalization...ds are all lower than they are in other first-worl...
...atments is the difficulty of aiming these treatmen...ealthy cells in the process. But a new study by Mc... into how scientists might develop therapies and d...ing normal healthy cells , Mick Bhatia, scientifi...search Institute in the Michael G. DeGroote School...
Other Biology News:New standard for popular stevia-based sweetener to assure product's quality 2Plastic and reconstructive surgery -- in brief 2Plastic and reconstructive surgery -- in brief 3Scientists can now differentiate between healthy cells and cancer cells 2
Rabbit Anti-D4-GDI Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Rabbit Anti-MAL Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human ADAM-12 (Meltrin alpha), amino terminal region Antibody, Unconjugated from CEDARLANE Laboratories Limited
Rabbit Anti-FLIP Polyclonal Antibody, Unconjugated from Abcam
Biology Products: